Exploring !Temporal !Patterns !in ! Hypertensive !Drug !Therapy - - PowerPoint PPT Presentation

exploring temporal patterns in hypertensive drug therapy
SMART_READER_LITE
LIVE PREVIEW

Exploring !Temporal !Patterns !in ! Hypertensive !Drug !Therapy - - PowerPoint PPT Presentation

Exploring !Temporal !Patterns !in ! Hypertensive !Drug !Therapy Sophia Wu 1 , Margret Bjarnadottir 2 , Eberechukwu Onukwugha 3 , Catherine Plaisant 4 , Sana Malik 5 1. MSIS, Smith School of Business 2. Assistant Prof, Smith School of Business


slide-1
SLIDE 1

Exploring !Temporal !Patterns !in ! Hypertensive !Drug !Therapy

  • 1. MSIS, Smith School of Business
  • 2. Assistant Prof, Smith School of Business
  • 3. Assistant Prof, School of Pharmacy
  • 4. Research Scientist, HCIL
  • 5. Ph.D student in Computer Science

Sophia Wu1, Margret Bjarnadottir2, Eberechukwu Onukwugha3, Catherine Plaisant4, Sana Malik5

slide-2
SLIDE 2

INTRODUCTION

Patients’ Adherence to Medication Medication Possession Ratio (MPR)

  • Does not adequately capture different adherence patterns of

patients, which vary widely. Great importance as non-adherence can lead to worsening of conditions and health decline.

slide-3
SLIDE 3

Observe and Summarize Common Patterns in Hypertensive Drug Therapy

slide-4
SLIDE 4

DATA !DESCRIPTION

Pharmacy claims of 493,022 individuals 5 Drug Classes

Angiotension-Converting Enzyme-Inhibitors (Ace) Angiotension II Receptor Blockers (ARB) Calcium Channel Blockers (CCB) Beta blockers (Beta) Diuretics

slide-5
SLIDE 5

IDEAL !DRUG !USAGE !PATTERN

30 30 30 30 30 30 30

ACE

30 30 30 30 30

Days

slide-6
SLIDE 6

IDEAL !DRUG !USAGE !PATTERN

30 30 30 30 30 30 30 30 30 30 30 30 30

ACE Beta

30 30 30 30 30

Days

slide-7
SLIDE 7

IDEAL !DRUG !USAGE !PATTERN

30 30 30 30 30 30 30 30 30 30 30 30 30

ACE Beta

……

30 30 30 30 30

Days

slide-8
SLIDE 8

What !does !the !whole !picture !look !like?

1st !PASS

slide-9
SLIDE 9

Randomly selected 5000 events (180 individuals)

slide-10
SLIDE 10

What !if !we !narrow !down !a !little !bit?

1st !PASS 2nd !PASS

slide-11
SLIDE 11
slide-12
SLIDE 12
slide-13
SLIDE 13

MATCH WEIR

CCB Ace Beta Diur

slide-14
SLIDE 14

What !is !a !good !pattern?

1st !PASS 2nd !PASS 3rd !PASS

slide-15
SLIDE 15

NHLBI (2003), JNC 7 Express

slide-16
SLIDE 16

NHLBI (2003), JNC 7 Express

slide-17
SLIDE 17

NHLBI (2003), JNC 7 Express

slide-18
SLIDE 18

7

Search HF_4289 occurring during the CCB Drug usages&medical records for heart failure patients with ICD9 4289 HF_4289 CCB

slide-19
SLIDE 19

Why !are !Those !Heart !Failure ! Patients !Given !CCB?

slide-20
SLIDE 20

CCB Non-dihydropyridines (Good) Dihydropyridines (Bad)

slide-21
SLIDE 21

CCB Non-dihydropyridines (Good) Dihydropyridines (Bad)

slide-22
SLIDE 22

Are !there !any !heart !failure !patients !on ! bad !CCB?

1st !PASS 2nd !PASS 3rd !PASS 4th !PASS

slide-23
SLIDE 23

Bad CCB HF_any

slide-24
SLIDE 24

28

Search HF_any occurring during the Bad CCB Drug usages&medical records for heart failure patients on Bad CCB

slide-25
SLIDE 25

MEDICAL !STUDY

Atrial Fibrillation (AF) CCB Non-dihydropyridines (good) Dihydropyridines (bad)

slide-26
SLIDE 26

Do !those !heart !failure !patients !on !bad ! CCB !have !AF?

1st !PASS 2nd !PASS 3rd !PASS 4th !PASS 5th !PASS

slide-27
SLIDE 27

Search AF_any not occurring

89

Drug usages&medical records for heart failure patients on Bad CCB

slide-28
SLIDE 28

37454: Heart failure patients in total 416: Heart failure patients on CCB 89: Heart failure on bad CCB without AF

slide-29
SLIDE 29

37454: Heart failure patients in total 416: Heart failure patients on CCB 89: Heart failure on bad CCB without AF 0.24% among the heart failure Individuals

slide-30
SLIDE 30

37454: Heart failure patients in total 416: Heart failure patients on CCB 89: Heart failure on bad CCB without AF 0.24% among the heart failure Individuals

21% among the heart failure on CCB

slide-31
SLIDE 31

CRITICAL !FINDING

It is not compliant with medical guideline.

slide-32
SLIDE 32

CRITICAL !FINDING

It is not compliant with medical guideline.

Doctor’s mistake

slide-33
SLIDE 33

CRITICAL !FINDING

It is not compliant with medical guideline.

Doctor’s mistake

slide-34
SLIDE 34

What !does !the !pattern !look !like !before !and ! after !1st !heart !failure !inpatient !visit?

1st !PASS 2nd !PASS 3rd !PASS 4th !PASS 5th !PASS 6th !PASS

slide-35
SLIDE 35

Aggregating HF claims into 5 categories

slide-36
SLIDE 36

Category Place of Services Code

inpatient 21, 51, 56, 61

  • utpatient

all others urgent 20, 23, 41, 42 hospice 34 SNF(skilled nursing facility) 31, 32, 33

slide-37
SLIDE 37
slide-38
SLIDE 38

Cleaning multiple records

  • f inpatient visit
  • n the same day

Aggregating HF claims into 5 categories

slide-39
SLIDE 39

Search → Add Constraint

slide-40
SLIDE 40
slide-41
SLIDE 41

Cleaning multiple records

  • f inpatient visit
  • n the same day

Aligning by the first HF inpatient visit Aggregating HF claims into 5 categories

slide-42
SLIDE 42

Drug usages&medical records for heart failure patients on Bad CCB

slide-43
SLIDE 43

Patients with AF claims: started by taking good CCB and ACE → not long after first heart failure inpatient visit, dropped good CCB but took bad CCB instead. Patients without AF claims: started to take hypertensive drugs after first heart failure inpatient visit → dropped bad CCB Patients without AF claims: started to take hypertensive drugs after first heart failure inpatient visit → continued to take bad CCB for some periods of time

slide-44
SLIDE 44

CONCLUSION

Patterns are far from ideal

  • Doctors may have given wrong prescriptions 


(use of bad CCB)

  • EventFlow:
  • visualization reveals limitations of Medical Possession Ratio
  • detect common patterns & specific cases
slide-45
SLIDE 45

FUTURE !AVENUES

Clustering: discovering underlying patterns of behavior of

patients taking medicine, then analyzing the different clusters in EventFlow

  • Statistic Analysis: logistic regression, including Charlson

Comorbidity Index (CCI), to quantify drug impacts on outcomes

  • EventFlow:
  • Generating hypothesis


(eg. Patient on bad CCB may have higher readmission rate)

  • Supporting the statistic analysis findings
slide-46
SLIDE 46

THANK !YOU

For more information: Email: zhusenru.wu@rhsmith.umd.edu margret@rhsmith.umd.edu Website: http://www.cs.umd.edu/hcil/eventflow May 29, 2014 HCIL Symposium